Tic Disorder
11
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
Scalp Acupuncture Treatment for Chronic Tic Disorders in Children
Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Phase III Study of 5LGr to Treat Tic Disorder
Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections